Synjardy XR 25 mg/1 (Empagliflozin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 25 mg/1

Synjardy XR 25 mg/1 is an extended-release tablet combining empagliflozin and metformin hydrochloride. It is designed to help manage type 2 diabetes by improving blood sugar control. This medication is suitable for adults and is available in a 90-tablet bottle.

Strength

25 mg/1

Pack Size

90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0295-78)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Synjardy XR 25 mg/1 is primarily used to improve glycemic control in adults with type 2 diabetes. The combination of empagliflozin and metformin hydrochloride works to lower blood sugar levels. This medication is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. It is important to consult with a healthcare provider to determine if Synjardy XR 25 mg/1 is appropriate for your specific needs.

Side Effects

Common effects of Synjardy XR 25 mg/1 may include gastrointestinal discomfort, such as nausea, diarrhea, or vomiting. Some individuals may also experience urinary tract infections or hypoglycemia, especially when combined with other diabetes medications. It is important to monitor blood sugar levels regularly and report any severe or persistent side effects to a healthcare provider.

Precautions & Warnings

Synjardy XR 25 mg/1 should be taken exactly as prescribed by a healthcare provider. It is important to follow the dosage instructions carefully and not to crush or chew the extended-release tablets. This medication should be stored at room temperature and kept out of reach of children. Individuals with certain medical conditions, such as kidney or liver disease, should discuss potential risks with their healthcare provider before starting this medication.

Avoid Interactions

Synjardy XR 25 mg/1 may interact with other medications, including certain antibiotics, diuretics, and other diabetes drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be limited, as it can increase the risk of lactic acidosis. Always consult with a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

Synjardy XR 25 mg/1 is used to improve blood sugar control in adults with type 2 diabetes.

Synjardy XR 25 mg/1 should be taken orally, with or without food, as prescribed by your healthcare provider.

Common side effects may include gastrointestinal discomfort, urinary tract infections, and hypoglycemia.

Alcohol consumption should be limited while taking Synjardy XR 25 mg/1, as it can increase the risk of lactic acidosis.

Synjardy XR 25 mg/1 should be stored at room temperature and kept out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.